Portia Kit
Product Images NDC 0555-9020

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Portia (NDC 0555-9020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

FDA Label Image

Image 2

FDA Label Image

Image 3

Image 3
This appears to be a table showing different ranges of blood clotting incidents in women based on their pregnancy status and use of COC (combination oral contraceptive). The table also includes a note about the pregnancy data being based on actual duration of pregnancy in reference studies and a model assumption that pregnancy lasts nine months.*
FDA Label Image

Image 4

FDA Label Image

Image 5

FDA Label Image

Image 6

Image 6
This is a prescription drug called "Prticd" containing levonorgestrel and ethinyl estradiol in tablet form with a recommended storage temperature of 20°C to 25°C. The text also includes a calendar showing the days of the week.*
FDA Label Image

Image 7

Image 7
This is a description of a package of oral contraceptive pills containing 6 blister cards, each with 28 tablets, 21 of which are pink and contain 0.15mg levonorgestrel and 0.03mg ethinyl estradiol while 7 tablets are inert and white. The product is intended to prevent pregnancy but does not protect against STDs including HIV infection/AIDS. The NDC codes are 0555-0020-58 and 0555-9020-58.*
FDA Label Image

Image 8

Image 8
This is a description for a medication product. The product contains 6 blister cards, each with either 26 or 28 tablets of the combination of levonorgestrel and ethinyl estradiol tablets. The tablets are pink or white and should be stored at controlled room temperature. The recommended dosage is one tablet daily for 28 consecutive days per menstrual cycle. The product information should be provided to the patient along with the prescription. The carton has labeling information for the patient and includes contact information for more product information. The product is manufactured by Teva Pharmaceuticals USA Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.